Vanguard Group’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.21M Buy
65,296
+14,198
+28% +$259K ﹤0.01% 3721
2025
Q3
$921K Sell
51,098
-2,757
-5% -$50.8K ﹤0.01% 3812
2025
Q2
$1.04M Sell
53,855
-7,673
-12% -$145K ﹤0.01% 3729
2025
Q1
$955K Buy
61,528
+3,744
+6% +$67K ﹤0.01% 3723
2024
Q4
$1.03M Buy
57,784
+1,785
+3% +$30.8K ﹤0.01% 3757
2024
Q3
$1.01M Buy
55,999
+5,257
+10% +$96K ﹤0.01% 3770
2024
Q2
$788K Buy
+50,742
New +$839K ﹤0.01% 3873

Other funds holding MDWD

Vanguard Group's MDWD Position: Q4 2025 in Review

Vanguard Group increased its MediWound (MDWD) stake by 28% in Q4 2025, buying an estimated $259K and bringing the position to 65,296 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

Vanguard Group first reported a position in MDWD in Q2 2024 and has held it in 7 quarters since. 78 funds tracked by Wall St. Rank hold MDWD as of Q4 2025.

  • Vanguard Group held 65,296 shares of MediWound worth $1.21M as of Q4 2025.
  • Vanguard Group bought 14,198 MediWound shares in Q4 2025, an estimated $259K.
  • MediWound made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3721 holding.
  • Vanguard Group first reported a position in MediWound in Q2 2024 and has held it in 7 quarters since.
  • 78 funds tracked by Wall St. Rank held MediWound as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.